Genetic modifiers of non-alcoholic fatty liver disease progression - PubMed (original) (raw)

Review

. 2011 Nov;1812(11):1557-66.

doi: 10.1016/j.bbadis.2011.07.017. Epub 2011 Aug 5.

Affiliations

Free article

Review

Genetic modifiers of non-alcoholic fatty liver disease progression

Quentin M Anstee et al. Biochim Biophys Acta. 2011 Nov.

Free article

Abstract

Non-alcoholic fatty liver disease (NAFLD) is now recognised as the most common cause of liver dysfunction worldwide. However, whilst the majority of individuals who exhibit features of the metabolic syndrome including obesity and insulin resistance will develop steatosis, only a minority progress to steatohepatitis, fibrosis and cirrhosis. Subtle inter-patient genetic variations and environment interact to determine disease phenotype and influence progression. A decade after the sequencing of the human genome, the comprehensive study of genomic variation offers new insights into the modifier genes, pathogenic mechanisms and is beginning to suggest novel therapeutic targets. We review the current status of the field with particular focus on advances from recent genome-wide association studies.

2011 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources